Product correctly added to cart.

5-Norbornene-2,3-dimethanol (mixture of endo- and exo-, predominantly endo-isomer)
View 3D

Biosynth logo

5-Norbornene-2,3-dimethanol (mixture of endo- and exo-, predominantly endo-isomer)

CAS: 85-39-2

Ref. 3D-AAA08539

1g
Discontinued
5gDiscontinued
10gDiscontinued
25gDiscontinued
100mg
Discontinued
500mgDiscontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .


Product Information

Name:
5-Norbornene-2,3-dimethanol (mixture of endo- and exo-, predominantly endo-isomer)
Synonyms:
  • 2,3-Bis(hydroxymethyl)-5-norbornene
  • 5,6-Bis(hydroxymethyl)bicyclo[2.2.1]hept-2-ene
  • 5,6-Di(hydroxymethyl)bicyclo[2.2.1]hept-2-ene
  • 5-Norbornene-2,3-dimethanol
  • Ai3-26535
  • Bicyclo[2.2.1]hept-5-ene-2,3-dimethylol
  • NSC 31985
  • [3-(Hydroxymethyl)-2-bicyclo[2.2.1]hept-5-enyl]methanol
  • [3-(Hydroxymethyl)bicyclo[2.2.1]hept-5-en-2-yl]methanol
Description:

5-Norbornene-2,3-dimethanol (5NBMD) is a carboxylic acid that has two isomers. The endo isomer predominates in the mixture. 5NBMD has been shown to be effective against methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium perfringens, although is not active against acid-fast bacteria such as Mycobacterium tuberculosis or Mycobacterium avium complex. Gatifloxacin has shown anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
154.21 g/mol
Formula:
C9H14O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Inquiry about discontinued product: 3D-AAA08539 5-Norbornene-2,3-dimethanol (mixture of endo- and exo-, predominantly endo-isomer)

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".